164 related articles for article (PubMed ID: 24503785)
1. Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.
De Bari B; Fiorentino A; Greto D; Ciammella P; Arcangeli S; Avuzzi B; D'Angelillo RM; Desideri I; Kirienko M; Marchiori D; Massari F; Fundoni C; Franco P; Filippi AR; Alongi F
Tumori; 2013; 99(6):637-49. PubMed ID: 24503785
[TBL] [Abstract][Full Text] [Related]
2. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.
Sylvester J; Grimm P; Blasco J; Meier R; Spiegel J; Heaney C; Cavanagh W
Urology; 2001 Aug; 58(2 Suppl 1):65-70. PubMed ID: 11502452
[TBL] [Abstract][Full Text] [Related]
3. PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients.
Fersino S; Borghesi S; Jereczek-Fossa BA; Arcangeli S; Mortellaro G; Magrini SM; Alongi F;
Radiol Med; 2021 Mar; 126(3):460-465. PubMed ID: 32852750
[TBL] [Abstract][Full Text] [Related]
4. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations.
Mukherji D; Youssef B; Dagher C; El-Hajj A; Nasr R; Geara F; Rabah D; Al Dousari S; Said R; Ashou R; Wazzan W; Jabbour M; Farha G; Al Hamdani N; Al Hallaq Y; Ghazal H; Dbouk H; Bachir B; El Khoury C; Sakr G; Hussain HK; Sayyid K; Ibrahim K; Haidar M; Zouain N; Bitar N; Alameh W; Abbas F; Faddoul S; Nemer E; Assaf G; Farhat F; Bulbul M; Temraz S; Shamseddine A; Gillessen S; Omlin A; Khauli R
World J Urol; 2020 Mar; 38(3):681-693. PubMed ID: 31297628
[TBL] [Abstract][Full Text] [Related]
6. Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.
Akaza H; Hinotsu S; Cooperberg MR; Chung BH; Youl Lee J; Umbas R; Tsukamoto T; Namiki M; Carroll P
Jpn J Clin Oncol; 2013 Jul; 43(7):756-66. PubMed ID: 23723314
[TBL] [Abstract][Full Text] [Related]
7. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure.
D'Amico AV; Moul JW; Carroll PR; Cote K; Sun L; Lubeck D; Renshaw AA; Loffredo M; Chen MH
J Natl Cancer Inst; 2004 Apr; 96(7):509-15. PubMed ID: 15069112
[TBL] [Abstract][Full Text] [Related]
8. Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.
Morgia G; Russo GI; Tubaro A; Bortolus R; Randone D; Gabriele P; Trippa F; Zattoni F; Porena M; Mirone V; Serni S; Del Nero A; Lay G; Ricardi U; Rocco F; Terrone C; Pagliarulo A; Ludovico G; Vespasiani G; Brausi M; Simeone C; Novella G; Carmignani G; Leonardi R; Pinnarò P; De Paula U; Corvò R; Tenaglia R; Siracusano S; Mantini G; Gontero P; Savoca G; Ficarra V;
BJU Int; 2016 Jun; 117(6):867-73. PubMed ID: 26332130
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.
Onozawa M; Hinotsu S; Tsukamoto T; Oya M; Ogawa O; Kitamura T; Suzuki K; Naito S; Namiki M; Nishimura K; Hirao Y; Akaza H
Jpn J Clin Oncol; 2014 Oct; 44(10):969-81. PubMed ID: 25098707
[TBL] [Abstract][Full Text] [Related]
10. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
[TBL] [Abstract][Full Text] [Related]
11. The role of induction androgen deprivation prior to radical prostatectomy.
Soloway MS; Watson R
Eur Urol; 1996; 29 Suppl 2():114-8. PubMed ID: 8717473
[TBL] [Abstract][Full Text] [Related]
12. The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer.
Alongi F; De Bari B; Franco P; Ciammella P; Chekrine T; Livi L; Jereczek-Fossa BA; Filippi AR;
Radiol Med; 2013 Jun; 118(4):660-78. PubMed ID: 23358818
[TBL] [Abstract][Full Text] [Related]
13. Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: a population-based study.
Lycken M; Garmo H; Adolfsson J; Stattin P; Holmberg L; Bill-Axelson A
Eur J Cancer; 2014 Jul; 50(10):1789-1798. PubMed ID: 24736041
[TBL] [Abstract][Full Text] [Related]
14. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
15. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
Berenguer Sánchez A
Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
[No Abstract] [Full Text] [Related]
16. [Surgical and medical treatment for localized prostate cancer].
Kawai K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
[TBL] [Abstract][Full Text] [Related]
17. Management strategies for locally advanced prostate cancer.
Jani AB
Drugs Aging; 2006; 23(2):119-29. PubMed ID: 16536635
[TBL] [Abstract][Full Text] [Related]
18. Critical evaluation of hormonal therapy for carcinoma of the prostate.
Chodak GW; Keane T; Klotz L;
Urology; 2002 Aug; 60(2):201-8. PubMed ID: 12137810
[No Abstract] [Full Text] [Related]
19. Prostate cancer update: 2007.
Lin AM; Small EJ
Curr Opin Oncol; 2008 May; 20(3):294-9. PubMed ID: 18391629
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of prostate cancer].
Romics I
Orv Hetil; 2010 Apr; 151(14):580-3. PubMed ID: 20332076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
